26 MAY 2021 – BACK TO THE FUTURE: HIV VACCINE LEARNINGS
An event to engage scientists, clinicians, industry, funders, and community representatives on how best to learn from past efficacy trials to inform future vaccine development efforts.
Calendar events
Enterprise – Communication Training Workshop 2021 (announcement)
/in Events /by Roger TatoudThe Global HIV Vaccine Enterprise at the IAS – International AIDS Society, and IAVI, are pleased to announce a Communication Training Workshop for early-mid career African researchers working in HIV vaccine research and development.
HIV R4P Virtual News
/in Events /by Roger TatoudHIV vaccine highlights and spotlights – To help attendees manage their time and navigate a busy programme, the Enterprise has developed an HIV vaccine R&D roadmap which covers active immunization and passive immunization with broadly neutralizing antibodies (bNAbs), especially VRC01.
Making mAb Accessible webinar
/in Events /by Roger TatoudThe Global HIV Vaccine Enterprise at the International AIDS Society and IAVI are pleased to invite you to join a webinar to discuss challenges and opportunities on the Access to future monoclonal antibodies for HIV prevention:
“Making monoclonal antibodies broadly accessible to communities most at risk of HIV/AIDS – What would it take?’’
VIRTUAL WORKSHOP SERIES
/in Events /by Roger TatoudNOW VIRTUAL ! This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.
Enterprise workshop trial design R4P
/in Events /by Roger TatoudThis scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.
Enterprise Workshop – Kigali 2019
/in Events /by Roger TatoudAre you an African researcher or a clinician working on HIV vaccine research and development (R&D)? Are you interested in sharing your experience and the challenges you face in your daily work? Are you keen to develop practical solutions to support African researchers towards the development of a safe and effective HIV vaccine?
The Global HIV Vaccine Enterprise invites you to apply to attend an interactive half-day workshop in Kigali.
HIV Vaccine R&D at the IAS Science Conference 2019
/in Events /by Roger TatoudThe IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational research that moves science into policy and practice. Through its open and inclusive programme development, the meeting sets the gold standard of HIV research featuring highly diverse and cutting-edge studies.
HIV Vaccine research and development will be very much featured before and during the conference.
About
Established in 2003, the Global HIV Vaccine Enterprise (the Enterprise) became a programme of IAS – the International AIDS Society – in 2018. The Enterprise unites stakeholders to share knowledge, foster collaboration, enable solutions and expand support critical to the development of – and future access to – an HIV vaccine.
Global HIV Vaccine Enterprise
IAS – the International AIDS Society
Avenue de France 23
CH-1202 Geneva
Switzerland
Contact Us
